Axcelis Enters A Low-Momentum Phase As Upside Follow-Through Fades

Axcelis Technologies (NASDAQ: ACLS) is currently in Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly charts. Based on the stock's internal structure, this phase is likely to be characterised by consolidation and sluggish price action rather than a trending move.

Benzinga • 34 minutes ago

Why Axcelis Technologies (ACLS) Outpaced the Stock Market Today

Axcelis Technologies (ACLS) concluded the recent trading session at $95.72, signifying a +2.81% move from its prior day's close.

Zacks Investment Research • Jan 13, 2026

NuScale Power Is Interesting, but Here's What I'd Buy Instead

NuScale could be an attractive energy source as tech giants monitor nuclear energy developments. However, NuScale is years away from commercialization, which makes it a very risky stock.

The Motley Fool • Jan 10, 2026

Ignore the Noise: 3 AI Stocks Set to Surge 200% by the End of the Decade

Tech giants remain committed to spending heavily on their AI infrastructure buildouts in 2026. AI chipmakers have led the stock market's rally for several years, but the next wave of growth is likely to come from a different batch of stocks.

The Motley Fool • Jan 9, 2026

Axcelis to Participate in the 28th Annual Needham Growth Conference

BEVERLY, Mass., Jan. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced management is scheduled to participate at the 28th Annual Needham Growth Conference on Tuesday, January 13th, 2026, at The Lotte NY Palace Hotel in New York, NY.

PRNewsWire • Jan 8, 2026

Veeco Instruments Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Veeco Instruments Inc. - VECO

NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

PRNewsWire • Jan 7, 2026

Axcelis Director Sells 2,000 Shares as Veeco Merger Advances Through Regulatory Review

2,000 direct shares were sold for $172,100 at $86.05 per share on Dec. 17, 2025. This transaction represented 21.10% of the executive's direct holdings, reducing the position from 9,477 to 7,477 shares.

The Motley Fool • Jan 2, 2026

Axcelis Technologies (ACLS) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $82.8, denoting a -1.08% move from the preceding trading day.

Zacks Investment Research • Dec 25, 2025

Axcelis Technologies (ACLS) Registers a Bigger Fall Than the Market: Important Facts to Note

Axcelis Technologies (ACLS) reached $86.32 at the closing of the latest trading day, reflecting a -1.08% change compared to its last close.

Zacks Investment Research • Dec 17, 2025

Axcelis to Showcase Advanced Ion Implant Solutions at SEMICON Japan 2025

BEVERLY, Mass. , Dec. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today its participation in SEMICON Japan 2025, taking place December 17–19 at Tokyo Big Sight in Tokyo, Japan.

PRNewsWire • Dec 10, 2025